Health Ministry Launches 3rd Respiratory Infection Prevention Campaign

The Ministry of Health and Social Security launched the 3e edition of its respiratory infection prevention campaign under the slogan “A respiratory infection is anything but trendy.” Running as the winter season begins and seasonal viruses start circulating, the public health initiative addresses influenza, COVID-19, respiratory syncytial virus (RSV) bronchiolitis, pertussis, and pneumococcal pneumonia to prevent severe complications among vulnerable populations.

The 2026 Shift Toward Intranasal Immunization for Pediatric Populations

The 2026 campaign centers on vaccination, specifically introducing a nasal spray influenza vaccine for children aged 2 through 17 years. Families can access this option directly during appointments with general practitioners or pediatricians. While pediatric influenza typically presents as mild illness, it regularly forces children out of school, daycare, and normal daily routines for multiple days. Public health officials note that needle-free administration improves acceptance among both children and parents, while simultaneously limiting viral transmission to vulnerable household contacts.

Injectable standard flu vaccines remain fully accessible for families preferring traditional administration, individuals with clinical contraindications to the intranasal formula, or in the event of nasal spray stock exhaustion. These injectable doses continue to be provided free of charge at local pharmacies upon presentation of a valid medical prescription, matching distribution protocols from the 2025-2026 winter season.

Targeting RSV Vulnerability in Older Adults

Beyond pediatric influenza, the health ministry’s campaign targets respiratory syncytial virus, a pathogen frequently recognized in infant bronchiolitis but also a severe threat to older adults. RSV infections in aging populations can trigger pulmonary complications, exacerbate preexisting cardiac or pulmonary conditions, and cause acute respiratory distress requiring hospitalization or resulting in death.

Immunization against RSV is currently available and state-supported for specific high-risk groups. Coverage extends to individuals aged 75 and older, particularly those residing in institutions, alongside adults aged 65 and older living with a comorbidity that elevates their risk of severe RSV complications. Health authorities advise residents to consult their primary care physicians to evaluate personal risk factors and secure access to the vaccine.

Public Health Guidance Emphasizes Non-Pharmaceutical Interventions

Alongside immunization efforts, the public health guidance emphasizes non-pharmaceutical interventions to curb viral transmission across communities. Recommendations include frequent handwashing with soap and water, daily room ventilation even during cold weather months, avoiding close contact with vulnerable individuals when experiencing symptoms, and wearing masks around healthcare settings or when coughing and sneezing. Public health officials also reiterate proper respiratory etiquette, advising individuals to cough or sneeze into the inner elbow rather than bare hands.

To monitor epidemiological trends, the Health Directorate resumed weekly publication of respiratory infection data in October. These reports track the progression of seasonal viral circulation throughout the winter months and remain accessible for public review online.

Disclaimer: The information provided in this article is for educational and scientific communication purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider regarding any medical condition, diagnosis, or treatment plan.